Calcium plus vitamin D supplementation during pregnancy reduces postpartum fat mass in adolescents: A randomized trial
American Journal of Human Biology · 2023
DOI: 10.1002/ajhb.23911 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Human Biology, 2023. Verfasst von Verônica Rached und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Calcium, Vitamin D. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
Background
Pregnancy during adolescence may increase the risk of overweight/obesity. There is evidence that increasing calcium intake, alone or vitamin D‐combined, may favor loss of weight and/or fat mass.
Objectives
We hypothesized that calcium supplementation during pregnancy reduces excessive fat accumulation during postpartum period. We aimed to investigate the effect of calcium plus vitamin D supplementation during pregnancy on body composition measurements throughout 1 year postpartum in Brazilian adolescents with habitually low calcium intake (~600 mg/day).
Methods
Adolescents (14–19 years) were randomly assigned to receive a daily supplement (600 mg of calcium plus 200 UI of cholecalciferol, n = 30) or a placebo ( n = 26) from 26 weeks of gestation until parturition. Body composition was determined at 5, 20, and 56 weeks postpartum by dual‐energy x‐ray absorptiometry. The effects of intervention group, time point, as well as their interaction were assessed using repeated measures mixed‐effects models.
Results
In the adjusted analysis, those supplemented showed lower total body mass [mean difference = −3.32 kg; confidence interval (CI) 95% −6.12 to −0.52 kg], trunk (−1.25 kg; CI 95% −2.34 to −0.15 kg), android (−0.29 kg; CI 95% −0.53 to −0.04 kg) and subcutaneous (−0.23 kg; CI 95% −0.43 to −0.03 kg) fat masses. In the supplemented group, BMI and postpartum weight retention significantly decreased from 5 to 20 weeks (−0.90 kg/m 2 and −1.76 kg, respectively; p < .05). At 56 weeks, BMI was still lower (−1.22 kg/m 2 ; p < .05) than 5 weeks.
Conclusions
Our findings suggest that increasing calcium intake through supplementation in combination with vitamin D contributes to a more pronounced reduction in total body mass overtime, mostly as a consequence of fat mass reductions in central body regions. This trial was registered at clinicaltrials.gov as NCT01732328.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil.
- Brazilian National Cancer Institute José Alencar Gomes da Silva, Coordenação de Prevenção e Vigilância, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
- School of Nutrition, University of the Republic, Montevideo, Uruguay.
ORCID-Profile: Verônica Rached, Flávia Fioruci Bezerra
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
Rached, V., Diogenes, M. E. L., Donangelo, C. M., & Bezerra, F. F. (2023). Calcium plus vitamin D supplementation during pregnancy reduces postpartum fat mass in adolescents: A randomized trial. American Journal of Human Biology. https://doi.org/10.1002/ajhb.23911
Vancouver
Rached V, Diogenes MEL, Donangelo CM, Bezerra FF. Calcium plus vitamin D supplementation during pregnancy reduces postpartum fat mass in adolescents: A randomized trial. American Journal of Human Biology. 2023. doi:10.1002/ajhb.23911
BibTeX
@article{Rached2023,
author = {Rached, Verônica and Diogenes, Maria Eduarda Leão and Donangelo, Carmen Marino and Bezerra, Flávia Fioruci},
title = {Calcium plus vitamin D supplementation during pregnancy reduces postpartum fat mass in adolescents: A randomized trial},
journal = {American Journal of Human Biology},
year = {2023},
doi = {10.1002/ajhb.23911}
}
EUVIMED